264 related articles for article (PubMed ID: 31694201)
1. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
Yan S; Vandewalle N; De Beule N; Faict S; Maes K; De Bruyne E; Menu E; Vanderkerken K; De Veirman K
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694201
[TBL] [Abstract][Full Text] [Related]
2. Targeting the TAM Receptors in Leukemia.
Huey MG; Minson KA; Earp HS; DeRyckere D; Graham DK
Cancers (Basel); 2016 Nov; 8(11):. PubMed ID: 27834816
[TBL] [Abstract][Full Text] [Related]
3. Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment.
Tanaka M; Siemann DW
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660000
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer.
Smart SK; Vasileiadi E; Wang X; DeRyckere D; Graham DK
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30501104
[TBL] [Abstract][Full Text] [Related]
5. Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response.
Davra V; Kimani SG; Calianese D; Birge RB
Cancers (Basel); 2016 Nov; 8(12):. PubMed ID: 27916840
[TBL] [Abstract][Full Text] [Related]
6. Gas6/AXL pathway: immunological landscape and therapeutic potential.
Zhai X; Pu D; Wang R; Zhang J; Lin Y; Wang Y; Zhai N; Peng X; Zhou Q; Li L
Front Oncol; 2023; 13():1121130. PubMed ID: 37265798
[TBL] [Abstract][Full Text] [Related]
7. TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Aehnlich P; Powell RM; Peeters MJW; Rahbech A; Thor Straten P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801886
[TBL] [Abstract][Full Text] [Related]
8. Accelerating AXL targeting for TNBC therapy.
Khera L; Lev S
Int J Biochem Cell Biol; 2021 Oct; 139():106057. PubMed ID: 34403827
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications.
Wium M; Ajayi-Smith AF; Paccez JD; Zerbini LF
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806258
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment.
Wang KH; Ding DC
Tzu Chi Med J; 2021; 33(3):250-256. PubMed ID: 34386362
[TBL] [Abstract][Full Text] [Related]
11. Immune Evasion Mechanism and AXL.
Son HY; Jeong HK
Front Oncol; 2021; 11():756225. PubMed ID: 34778071
[TBL] [Abstract][Full Text] [Related]
12. Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
Geng K; Kumar S; Kimani SG; Kholodovych V; Kasikara C; Mizuno K; Sandiford O; Rameshwar P; Kotenko SV; Birge RB
Front Immunol; 2017; 8():1521. PubMed ID: 29176978
[TBL] [Abstract][Full Text] [Related]
13. Immunological role of Gas6/TAM signaling in hemostasis and thrombosis.
Li F; Xu L; Li C; Hu F; Su Y
Thromb Res; 2024 Jun; 238():161-171. PubMed ID: 38723521
[TBL] [Abstract][Full Text] [Related]
14. AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew.
Auyez A; Sayan AE; Kriajevska M; Tulchinsky E
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638349
[TBL] [Abstract][Full Text] [Related]
15. The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity.
Meyer AS; Zweemer AJ; Lauffenburger DA
Cell Syst; 2015 Jul; 1(1):25-36. PubMed ID: 26236777
[TBL] [Abstract][Full Text] [Related]
16. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
[TBL] [Abstract][Full Text] [Related]
17. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review.
Zhang S; Xu XS; Yang JX; Guo JH; Chao TF; Tong Y
Onco Targets Ther; 2018; 11():509-519. PubMed ID: 29416351
[TBL] [Abstract][Full Text] [Related]
19. AXL receptor tyrosine kinase as a therapeutic target in NSCLC.
Okimoto RA; Bivona TG
Lung Cancer (Auckl); 2015; 6():27-34. PubMed ID: 28210148
[TBL] [Abstract][Full Text] [Related]
20. AXL as a Target in Breast Cancer Therapy.
Colavito SA
J Oncol; 2020; 2020():5291952. PubMed ID: 32148495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
